Yousif Capital Management’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.74M Sell
12,446
-934
-7% -$526K 0.08% 244
2026
Q1
$7.93M Sell
13,380
-659
-5% -$328K 0.09% 202
2025
Q4
$6.57M Sell
14,039
-965
-6% -$449K 0.07% 251
2025
Q3
$6.29M Sell
15,004
-995
-6% -$335K 0.07% 265
2025
Q2
$4.6M Sell
15,999
-208
-1% -$62.2K 0.05% 346
2025
Q1
$5M Sell
16,207
-160
-1% -$54.8K 0.06% 316
2024
Q4
$5.77M Sell
16,367
-658
-4% -$242K 0.06% 280
2024
Q3
$6.1M Sell
17,025
-2,183
-11% -$737K 0.07% 280
2024
Q2
$6.12M Sell
19,208
-2,728
-12% -$722K 0.07% 266
2024
Q1
$5.04M Sell
21,936
-688
-3% -$155K 0.06% 342
2023
Q4
$4.97M Sell
22,624
-101
-0.4% -$23.3K 0.06% 327
2023
Q3
$5.13M Sell
22,725
-1,235
-5% -$284K 0.07% 301
2023
Q2
$5.29M Sell
23,960
-126
-0.5% -$27.9K 0.06% 300
2023
Q1
$5.39M Sell
24,086
-120
-0.5% -$29.6K 0.07% 280
2022
Q4
$6.73M Buy
24,206
+310
+1% +$78.3K 0.09% 218
2022
Q3
$5M Sell
23,896
-2,208
-8% -$494K 0.07% 275
2022
Q2
$6.15M Buy
26,104
+825
+3% +$168K 0.08% 234
2022
Q1
$4.54M Buy
25,279
+873
+4% +$166K 0.05% 403
2021
Q4
$5.27M Buy
+24,406
New +$4.79M 0.05% 370

Other funds holding UTHR

Yousif Capital Management's UTHR Position: Q2 2026 in Review

Yousif Capital Management reduced its United Therapeutics (UTHR) stake by 7% in Q2 2026, selling an estimated $526K and leaving 12,446 shares worth $6.74M. The position accounts for 0.08% of the portfolio, ranked #244.

Yousif Capital Management first reported a position in UTHR in Q4 2021 and has held it in 19 quarters since. The position peaked at $7.93M in Q1 2026. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Yousif Capital Management held 12,446 shares of United Therapeutics worth $6.74M as of Q2 2026.
  • Yousif Capital Management sold 934 United Therapeutics shares in Q2 2026, an estimated $526K.
  • United Therapeutics made up 0.08% of Yousif Capital Management's portfolio in Q2 2026, its #244 holding.
  • Yousif Capital Management first reported a position in United Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • Yousif Capital Management's United Therapeutics position peaked at $7.93M in Q1 2026.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.